To demonstrate further the essential role of IL-10 in neonatal susceptibility to GBS, newborn mice were treated with anti-IL-10 receptor (IL-10R) mAb 12 h before NEM316 or BM110 GBS challenge. This evidence concerns the gene IL10RA and Guillain-Barre syndrome.